CFDE Workbench
DataKnowledgeCloudtrainingcoordination
CFDE Workbench

COL Q4KMQ2-1 GLY 000961 (Collection)

Taxon:

Homo sapiens

Taxonomy (Entity type)
Protein:

ANO6 HUMAN

Protein (Entity type)
Project:

Portal

Project (Entity type)
Dcc Asset:

glygen 2026 06 06 C2M2.zip

Processed File (Entity type)
Dcc:

GlyGen

DCC (Entity type)
Collection:

human proteoform glycosylation sites pdc ccrcc.csv

File (Entity type)
Description:Information for protein Q4KMQ2-1 in the context of file GLY_000961
Creation Time:2026-03-02 20:00:30.000000
Results found

Linked to

 

Label

Description

 

Compound

G83460ZZ

Compound (Entity type)

type="BaseComposition" mass="2044.69754491" permass="2577.29224757" monosaccharides="12" is_motif="F...

Compound

G00912UN

Compound (Entity type)

type="Composition" mass="2222.78300589" permass="2769.39335862" monosaccharides="11" is_motif="False...

Compound

G45395BF

Compound (Entity type)

type="Composition" mass="2368.84091476" permass="2943.48256763" monosaccharides="12" is_motif="False...

Compound

G86880BF

Compound (Entity type)

type="Composition" mass="2588.9356031" permass="3205.62420618" monosaccharides="14" is_motif="False"...

Protein

ANO6 HUMAN

Protein (Entity type)

Anoctamin-6

Post Translational Modification

q4kmq2-1 493asn 493asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q4kmq2-1 361asn 361asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q4kmq2-1 802asn 802asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

  • Compound

    G83460ZZ

    Compound (Entity type)

    type="BaseComposition" mass="2044.69754491" permass="2577.29224757" monosaccharides="12" is_motif="F...

  • Compound

    G00912UN

    Compound (Entity type)

    type="Composition" mass="2222.78300589" permass="2769.39335862" monosaccharides="11" is_motif="False...

  • Compound

    G45395BF

    Compound (Entity type)

    type="Composition" mass="2368.84091476" permass="2943.48256763" monosaccharides="12" is_motif="False...

  • Compound

    G86880BF

    Compound (Entity type)

    type="Composition" mass="2588.9356031" permass="3205.62420618" monosaccharides="14" is_motif="False"...

  • Protein

    ANO6 HUMAN

    Protein (Entity type)

    Anoctamin-6

  • Post Translational Modification

    q4kmq2-1 493asn 493asn defined go:0006486 go:0006487

    Post Translational Modification (Entity type)

    A Post Translational Modification

  • Post Translational Modification

    q4kmq2-1 361asn 361asn defined go:0006486 go:0006487

    Post Translational Modification (Entity type)

    A Post Translational Modification

  • Post Translational Modification

    q4kmq2-1 802asn 802asn defined go:0006486 go:0006487

    Post Translational Modification (Entity type)

    A Post Translational Modification

    • DISPLAY PER PAGE
    CFDE Workbench
    Report a bug
    Consortium
    About the CFDECF ProgramsCFDE CentersPartnershipsPilot Projects
    Community
    Workbench TutorialTraining & OutreachDocumentationGet QR CodesFunding Opportunities
    Resources
    Data & MetadataToolsChatbotUse CasesPublications
    @CFDE Workbench 2026
    The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
    Consortium
    About the CFDECF ProgramsCFDE CentersPartnershipsPilot Projects
    Community
    Workbench TutorialTraining & OutreachDocumentationGet QR CodesFunding Opportunities
    Resources
    Data & MetadataToolsChatbotUse CasesPublications
    CFDE Workbench
    Report a bug
    The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
    @CFDE Workbench 2026
    This repository is under review for potential modification in compliance with Administration directives.